SNDY Financials 07/16/2014 10:06:22 Solos Endosco
Post# of 1609
Posted On: 07/16/2014 11:06:18 AM
SNDY Financials 07/16/2014 10:06:22
Solos Endoscopy, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012
Total Revenue 398 383
Cost of Revenue 151 201
Gross Profit 247 181
Operating Expenses
Research and Development - -
Sales, General and Admin. 756 1,151
Non-Recurring Items - -
Other - -
Operating Income (509) (970)
Income From Continuing Operations
Add'l Income/Expense Items (80) 200
Earnings Before Interest and Tax (589) (769)
Interest Expense - 3
Earnings Before Tax (589) (772)
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (589) (572)
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (589) (772)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (589) (772)
Solos Endoscopy, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012
Total Revenue 398 383
Cost of Revenue 151 201
Gross Profit 247 181
Operating Expenses
Research and Development - -
Sales, General and Admin. 756 1,151
Non-Recurring Items - -
Other - -
Operating Income (509) (970)
Income From Continuing Operations
Add'l Income/Expense Items (80) 200
Earnings Before Interest and Tax (589) (769)
Interest Expense - 3
Earnings Before Tax (589) (772)
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (589) (572)
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (589) (772)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (589) (772)
(0)
(0)CYduct Diagnostics Inc. (CYDX) Stock Research Links
Scroll down for more posts ▼